Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Invesco Pharmaceuticals ETF (NY:PJP)

108.66 +0.47 (+0.43%)

Streaming Delayed Price Updated: 1:38 PM EST, Feb 23, 2026 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	39,007
Open	108.23
Bid (Size)	108.57 (100)
Ask (Size)	108.69 (100)
Prev. Close	108.19
Today's Range	108.13 - 108.81
52wk Range	72.25 - 110.78
Shares Outstanding	28,900
Dividend Yield	0.91%

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Merck Is Reportedly Splitting Its Pharma Division As Keytruda Patent Nears 2028 Expiry ↗

Today 6:31 EST

According to a Wall Street Journal report, the drugmaker said it will reorganize its human health segment into two separate units in an effort to better position its portfolio for the years ahead.

Via Stocktwits

FDA Commissioner Raises Concerns About US Pharma Lagging Behind China In Drug Development ↗

February 18, 2026

Marty Makary, in an interview with CNBC, further called for reforms that could streamline the process for starting trials on new treatments.

Via Stocktwits

Performance

YTD	+4.1%	+4.1%
1 Month	+3.5%	+3.5%
3 Month	+3.5%	+3.5%
6 Month	+20.4%	+20.4%
1 Year	+25.4%	+25.4%

More News

Why Did OCUL Stock Jump 13% In Pre-Market Today? ↗

January 15, 2026

Via Stocktwits

US-UK Near Landmark Zero-Tariffs Pharma Deal, Announcement Expected Soon: Report ↗

December 01, 2025

Via Stocktwits

Merck’s Blockbuster Drug Keytruda Gets Canadian Regulator’s Approval For Treating Cervical Cancer: Retail Investors Appear Divided ↗

July 21, 2025

Via Stocktwits

Eli Lilly CEO Slams PBM 'Rent Taking', Says They Drove Insulin List Prices To $275: 'We Can Disintermediate Them Easily' ↗

November 12, 2025

Via Benzinga

Trump's 100% Drug Tariff Will Hit Americans, Economist Says Buyers 'Eat The Cost,' Not Foreign Firms ↗

September 29, 2025

Via Benzinga

Mark Cuban Exposes How Wholesalers Force Pharmacies Into Near-Exclusive Deals, Detailing PBMs' 'Stranglehold' On Drug Pricing ↗

September 08, 2025

Via Benzinga

Mark Cuban Says Cutting PBM Fees Won't Reduce Pharmaceutical R&D Funding: 'Manufacturers Can Sell To Us For More' ↗

August 01, 2025

Via Benzinga

Trump's Pharma Tariffs Can Hit Novo Nordisk, Says Barclays Expert, But It's 'Difficult' To Predict As Drugmakers Have 'Complex Supply Chains' ↗

July 16, 2025

Via Benzinga

FDA May Fast-Track New Drug Reviews In Return For Companies Lowering Drug Prices: Report ↗

July 11, 2025

Via Stocktwits

Trump Threatens 200% Pharma Tariffs, But Analyst Says This Stock Is Immune And Expected To 'Benefit' From Levies ↗

July 11, 2025

Via Benzinga

Mark Cuban Corrects Elizabeth Warren As She Slams JNJ, PFE For Higher Prices And Zero Taxes On Big Pharma: 'PBMs Corrupt Healthcare' ↗

June 20, 2025

Via Benzinga

FDA Aims To Reduce Drug Application Review Time With New Voucher Program ↗

June 17, 2025

Via Stocktwits

Trump's Drug Price Order Hits PBMs Hardest: CVS, Cigna, UNH In Focus As Experts Highlight 'Racket,' Pricing Distortion ↗

May 19, 2025

Via Benzinga

Trump Says Prescription Drug Prices Set To Drop By 30% To 80% 'Almost Immediately' Thanks To 'Most Favored Nation' Plan, Mark Cuban Urges President To 'Force Transparency' ↗

May 11, 2025

Via Benzinga

Sandoz CEO Richard Saynor Slams Proposal For Europe-Wide List Price For New Medicines, Says Report ↗

April 28, 2025

Via Stocktwits

Trump Administration Considers Lowering US Drug Prices To International Levels: Report ↗

April 23, 2025

Via Benzinga

Eli Lilly, AbbVie, Bristol Myers, Regeneron, And Other Pharma Companies Slide As Donald Trump Confirms Tariffs On Pharma Companies ↗

April 11, 2025

Via Benzinga

FDA Commissioner Califf Candid on Trump's Impact: 'We Just Don't Know What's Going to Happen' ↗

November 13, 2024

Via Benzinga

FDA Set To Approve COVID-19 Vaccines As Soon As This Week: Stocks, ETFs To Watch ↗

August 19, 2024

Via Benzinga

COVID Activity Is Elevated Across 26 States In Summer Surge, Biden Remains In Isolation: 3 Vaccine Stocks To Watch ↗

July 18, 2024

Via Benzinga

Purdue Pharma Bankruptcy Plan Rejected by Supreme Court, Billionaire Sacklers to Face Lawsuits ↗

June 27, 2024

Via Benzinga

A Look At Pharma ETFs Post Q1 Earnings ↗

May 07, 2024

Via Talk Markets

A Look At Pharma ETFs After Q4 Earnings ↗

February 12, 2024

Via Talk Markets

Frequently Asked Questions

Is Invesco Pharmaceuticals ETF publicly traded?

Yes, Invesco Pharmaceuticals ETF is publicly traded.

What exchange does Invesco Pharmaceuticals ETF trade on?

Invesco Pharmaceuticals ETF trades on the New York Stock Exchange

What is the ticker symbol for Invesco Pharmaceuticals ETF?

The ticker symbol for Invesco Pharmaceuticals ETF is PJP on the New York Stock Exchange

What is the current price of Invesco Pharmaceuticals ETF?

The current price of Invesco Pharmaceuticals ETF is 108.66

When was Invesco Pharmaceuticals ETF last traded?

The last trade of Invesco Pharmaceuticals ETF was at 02/23/26 01:38 PM ET

What is the market capitalization of Invesco Pharmaceuticals ETF?

The market capitalization of Invesco Pharmaceuticals ETF is 3.14M

How many shares of Invesco Pharmaceuticals ETF are outstanding?

Invesco Pharmaceuticals ETF has 3M shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.